Nicholas Bravery
**HCA Healthcare (HCA) – Sharp Sell-Off Creates a Long-Term Opportunity?** πŸ“‰ HCA shares dropped sharply yesterday (~7-9%) after the company lowered its 2026 guidance due to a worse-than-expected payer mix shift β€” more uninsured patients coming off health insurance exchanges, creating a ~$400M headwind in Q2. While the short-term outlook disappointed, the fundamentals remain solid: - Leading U.S. hospital operator with strong market positions - Proven cost discipline and efficiency programs - Healthy cash flow generation and share repurchase track record At current levels (~$358–$364), HCA now trades at a compelling ~13x forward P/E β€” well below historical averages. **My long-term view (3–5+ horizon):** This looks like an attractive buying opportunity. Demographics, rising healthcare demand, and operational scale should drive recovery and growth. Analyst consensus remains Strong Buy with average targets ~$490–$505 (35–40% upside). Healthcare stocks are volatile, but high-quality operators like HCA tend to reward patient capital. A year or so back another healthcare giant UNH fell off a cliff and is well on the way to recovery after 18mths. Not expecting miracles from this one in the foreseeable few months but I will be adding to my position on any further weakness. *Never financial advice. $HCA (HCA Holdings Inc) $SPX500 https://x.com/Nick_Bravery
Not investment advice. The author may have financial interests in the mentioned instruments.
null
.